More young adults are turning to sterilization in the wake of the Supreme Court's Dobbs decision, new research finds. Jackie Ellison, PhD Pitt Health Policy and Management marketwatch.com/story/more-you…

1 in 3 women skip mammograms when faced with job loss and other hurdles, CDC says marketwatch.com/story/one-in-t…

While weight loss may be an important factor behind Wegovy's benefits for heart-failure patients, it's not the whole story, new research shows. Mikhail Kosiborod @midamericaheart Saint Luke's marketwatch.com/story/wegovys-…

Do we simply not care about older adults? So many reasons to wonder why -- society's response to ongoing covid deaths, pervasive ageism, and more. So, I took this on in a new column. cnn.com/2024/02/08/hea…

'We may not have the right bad guys here,' Sen. Romney said at today's drug-pricing hearing with CEOs of Merck, J&J, and Bristol Myers Squibb. marketwatch.com/story/j-j-merc…

“With government programs getting an 80% discount on Eliquis, lawmakers asking why the price of the drug is so high might get better answers from a mirror than from the pharmaceutical executives themselves.” Antonio Ciaccia

marketwatch.com/story/merck-j-… Eleanor Laise MarketWatch

As pharma execs face drug-price grilling on Capitol Hill, experts cite deeper problems under the radar marketwatch.com/story/merck-j-… Antonio Ciaccia 46brooklyn Research

So many talented and hardworking WSJ editors and reporters were laid off today in Washington. Our bureau will never be the same. Please hire them! Our tremendous loss can be your gain.

Our WSJ D.C. bureau lost some of its best editors and reporters today. It's been absolutely gutting, and they all have families and lives to think about. Please remember there are human beings sacrificing a whole lot to bring you the news and hold people in power to account.

Medicare patients with highest COVID risks were less likely to get treatment, study finds. marketwatch.com/story/medicare… Michael L. Barnett HMS HCP

U.S. women's health ranks on par with Kazakhstan, according to latest global index from Hologic marketwatch.com/story/u-s-wome…

What is Wegovy worth to your employer? We'll hear more on this during the lunchtime discussion today at #JPM24 marketwatch.com/story/what-is-…

Eli Lilly launches home delivery of obesity drug Zepbound, but warns against cosmetic use Antonio Ciaccia Caroline Apovian MD $LLY marketwatch.com/story/eli-lill…

Biotech stocks set for a rebound in 2024, analysts say. From Eleanor Laise marketwatch.com/story/biotech-…

5 obesity-drug trends to watch in 2024. Who can compete with $LLY and $NVO? marketwatch.com/story/five-obe… Caroline Apovian MD

Many thanks to Eleanor Laise MarketWatch for covering our study: marketwatch.com/story/hospital…; link to study JAMA Health Forum: jamanetwork.com/journals/jama-… Michael Chernew

Hospitals bill 50% more for a colonoscopy than surgical centers do, new research shows. Ge Bai Johns Hopkins Bloomberg School of Public Health marketwatch.com/story/hospital…

White House claims authority to break patents on certain high-cost drugs marketwatch.com/story/white-ho…

As Supreme Court weighs Purdue Pharma bankruptcy, families say the process has compounded their pain. Ed Bisch Cynthia C. Munger Prof Pamela Foohey Cardozo School of Law marketwatch.com/story/as-supre…

Supreme Court set to hear Purdue Pharma case that could shake up opioid settlement--and the bankruptcy process. Debtwire HLS Bankruptcy marketwatch.com/story/supreme-…